Trial Condition(s):

Erythema, Skin recovery

A study to gain information how well dexpanthenol dermal spray helps the face skin to recover after cosmetic lasering

Bayer Identifier:

20505 Identifier:


EudraCT Number:

Not Available

EU CT Number:

Not Available

Study Completed

Trial Purpose

In this study, researchers want to learn more about the effect of dexpanthenol dermal spray on skin recovery and reduction of skin redness after a dermatological procedure (non-ablative laser) on the face for treatment of fine wrinkles, scars, open pores and change of pigmentation.
After the dermatological procedure, participants will return within 3 weeks for 4 visits to the study center to investigate the skin conditions such redness, irritation, softness and possible side effects. In addition, study participants will be asked about their general acceptance of dexpanthenol dermal spray.

Inclusion Criteria
- Phototypes I or II according to the Fitzpatrick scale
 - Participants willing to perform the dermatological procedure (non-ablative laser) on the face for treatment of fine wrinkles, scars and open pores, rosacea, poikiloderma, and melasma
 - Normal eye examination
Exclusion Criteria
- Cutaneous pathologies and/or injuries as psoriasis, sensible skin, cancer of the skin, rosacea, atopic dermatitis or other medical criteria to be considered at the moment of the evaluation;
 - Hyperpigmentation in the test area that intervenes with the evaluation of possible reactions
 - Active cutaneous pathologies and/or injuries (local and/or disseminated) in the evaluation area
 - Aesthetic or dermatological treatment in the area of evaluation up to 04 weeks before the selection

Trial Summary

Enrollment Goal
Trial Dates
Could I receive a placebo?
Bepantol® Derma Spray (BAY207543)
Accepts Healthy Volunteers

Where to Participate


Medcin Instituto da Pele

Sao Paulo, Brazil, 06023-070

Trial Design